NNMX Projected Dividend Yield

Nanomix Corp ( OTCBB : NNMX )

Nanomix is a pre-clinical and clinical-stage pharmaceutical company focused on the clinical development, outsourced contract manufacture and test marketing for commercialization of carbohydrate-based patented formulation of investigative materials as medical food, supplements, drug and drug combination, and other clinical exploratory out sourced exploratory peptide therapeutic options. All agents are targeted designed to help manage blood sugar. Co. has also developed and produces and test market sells SUGARDOWN®, a non-systemic complex carbohydrate-based dietary food supplement to support healthy post-meal blood glucose using proprietary processes and technology.

20 YEAR PERFORMANCE RESULTS